무릎 골관절염 치료를 위한 글로벌 히알루론산 시장 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2032년까지의 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Healthcare Global Hyaluronic Acid Market For Knee Osteoarthritis Treatment Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 무료 샘플 보고서 무료 샘플 보고서 구매하기 전에 문의 구매하기 전에 문의 지금 구매 지금 구매

무릎 골관절염 치료를 위한 글로벌 히알루론산 시장 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2032년까지의 예측

  • Healthcare
  • Published Report
  • Apr 2025
  • Global
  • 350 Pages
  • 테이블 수: 500
  • 그림 수: 48
  • Author : Sachin Pawar
지금 구매 지금 구매 샘플요청 샘플요청
Nucleus Nucleus

민첩한 공급망 컨설팅으로 관세 문제를 극복하세요

공급망 생태계 분석이 이제 DBMR 보고서의 일부가 되었습니다

Global Hyaluronic Acid Market For Knee Osteoarthritis Treatment Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Chart Image USD 2.28 Billion USD 4.29 Billion 2024 2032
Diagram 예측 기간
 2025 –2032
Diagram 시장 규모(기준 연도)
 USD 2.28 Billion
Diagram 시장 규모(예측 연도)
 USD 4.29 Billion
Diagram 연평균 성장률
 %
Diagram 주요 시장 플레이어
  • LG Chem
  • Bioventus LLC
  • Seikagaku Corporation

무릎 골관절염 치료를 위한 글로벌 히알루론산 시장 시장 세분화, 제품 유형별(단일 주사(단상), 3회 주사 요법(3상), 5회 주사 요법(5상)), 제형(가교 히알루론산, 비가교 히알루론산), 분자량(고분자량(HMW) HA, 저분자량(LMW) HA, 중간 분자량 HA), 치료 목표(점성 보충, 항염증 및 통증 감소, 연골 보호 및 재생), 최종 사용자(병원, 정형외과 클리닉, 외래 수술 센터, 전문 통증 관리 센터), 유통 채널(직접 입찰, 소매 및 온라인 약국, 기타), 국가(미국, 캐나다, 멕시코, 독일, 프랑스, ​​영국, 이탈리아, 러시아, 스페인, 터키, 네덜란드, 스위스, 벨기에, 스웨덴, 오스트리아, 덴마크, 노르웨이, 폴란드 및 기타 유럽 국가, 중국, 인도, 일본, 한국, 호주, 인도네시아, 태국, 말레이시아, 베트남. 필리핀, 대만, 싱가포르, 뉴질랜드, 필리핀, 카자흐스탄, 브루나이 및 기타 아시아 태평양 국가, 사우디아라비아, 남아프리카공화국, 이집트, UAE, 이스라엘, 쿠웨이트, 카타르, 이란, 오만, 알제리, 나이지리아, 이라크, 모로코, 케냐, 가나, 튀니지, 탄자니아, 요르단, 리비아, 바레인, 앙골라, 카메룬, 코트디부아르, 짐바브웨, 세네갈, 모리타니, 토고, 모리셔스, 보츠와나 및 기타 중동 및 아프리카 국가, 브라질, 아르헨티나, 칠레, 페루, 콜롬비아, 에콰도르, 베네수엘라, 파나마, 우루과이, 도미니카 공화국 및 기타 남미 국가 - 2032년까지의 산업 동향 및 전망

무릎 골관절염 치료 시장을 위한 히알루론산 시장

 무릎 골관절염 치료를 위한 히알루론산 시장 규모

  • 무릎 골관절염 치료를 위한 글로벌 히알루론산 시장은 2024년에 22억 8천만 달러 로 평가되었으며 2032년까지 42억 9천만 달러에 도달할 것으로 예상됩니다.
  • 2025년부터 2032년까지의 예측 기간 동안 시장은 주로 예상되는 치료법 출시에 의해 주도되어 8.3%의 CAGR로 성장할 것으로 예상됩니다.
  • 무릎 골관절염 유병률 증가와 최소 침습 치료에 대한 선호도 증가로 히알루론산 기반 치료법에 대한 수요가 증가하고 있습니다. 또한, 점성 보충 요법의 이점에 대한 인식이 높아짐에 따라 시장 성장이 더욱 가속화되고 있습니다.

무릎 골관절염 치료 시장을 위한 히알루론산 시장무릎 골관절염 치료 시장을 위한 히알루론산 시장

무릎 골관절염 치료를 위한 히알루론산 시장 분석

  • 히알루론산은 체내, 특히 결합 조직, 피부, 그리고 관절을 윤활하는 활액에 존재하는 천연 물질입니다. 무릎 골관절염 치료에서 히알루론산은 관절 기능을 개선하고 통증을 완화하는 점성 보충제로 사용됩니다. 히알루론산을 무릎 관절에 직접 주입하면 쿠션 효과를 높이고, 운동 중 마찰을 줄이며, 연골 재생을 촉진하여 골관절염 증상 완화에 도움을 줄 수 있습니다. 이 치료는 운동 능력 회복, 삶의 질 향상, 그리고 질병 진행 지연을 목표로 합니다.
  • 북미는 무릎 골관절염 치료를 위한 히알루론산 시장에서 선두 지역으로 부상하고 있는데, 이는 잘 확립된 의료 시스템과 첨단 비수술적 관절 치료 옵션의 높은 도입에 힘입은 것입니다.
    • 예를 들어, 미국은 환자 인식 증가와 유리한 보상 정책에 힘입어 관절 내 히알루론산 주사의 강력한 수용을 보이고 있습니다.
  • 이 지역은 골관절염 환자의 이동성과 삶의 질을 개선하는 데 중점을 두고 있으며, 이를 통해 히알루론산 기반 치료법의 혁신과 시장 확대가 지속적으로 이루어지고 있습니다.

무릎 골관절염 치료를 위한 히알루론산 시장 세분화 및 보고서 범위

속성

무릎 골관절염 치료를 위한 히알루론산 시장 주요 시장 통찰력

다루는 세그먼트
  • 제품 유형별 : 단일 주사(단상), 3회 주사 요법(삼상), 5회 주사 요법(오상)
  • 제형별:  가교 히알루론산, 비가교 히알루론산
  • 분자량별:  고분자량(HMW) HA, 저분자량(LMW) HA, 중분자량 HA
  • 치료 목표별:  점성 보충, 항염증 및 통증 감소, 연골 보호 및 재생
  • 최종 사용자별:  병원, 정형외과 클리닉, 외래 수술 센터, 전문 통증 관리 센터
  • 유통 채널별 : 직접 입찰, 소매 및 온라인 약국, 기타

포함 국가

북아메리카

  • 이
  • 캐나다
  • 멕시코

유럽

  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 러시아 제국
  • 스페인
  • 칠면조
  • 네덜란드
  • 스위스
  • 벨기에
  • 스웨덴
  • 오스트리아
  • 덴마크
  • 노르웨이
  • 폴란드
  •  유럽의 나머지 지역

아시아 태평양

  • 중국
  • 인도
  • 일본
  • 대한민국
  • 호주
  • 인도네시아 공화국
  • 태국
  • 말레이시아
  • 베트남
  • 필리핀 제도
  • 대만
  • 싱가포르
  • 뉴질랜드
  • 필리핀 제도
  • 카자흐스탄
  • 브루나이
  • 아시아 태평양의 나머지 지역

중동 및 아프리카

  • 사우디 아라비아
  • 남아프리카 공화국
  • 이집트
  • 아랍에미리트
  • 이스라엘
  • 쿠웨이트
  • 카타르
  • 이란
  • 오만
  • 알제리
  • 나이지리아
  • 이라크
  • 모로코 가죽
  • 케냐
  • 가나
  • 튀니지
  • 탄자니아
  • 요르단
  • 리비아
  • 바레인
  • 앙골라
  • 카메룬
  • 상아 해안
  • 짐바브웨
  • 세네갈
  • 모리타니
  • 토고
  • 모리셔스
  • 보츠와나
  • 중동 및 아프리카의 나머지 지역

남아메리카

  • 브라질
  • 아르헨티나
  • 칠레
  • 페루
  • 콜롬비아
  • 에콰도르
  • 베네수엘라
  • 파나마
  • 우루과이
  • 도미니카 공화국
  • 남미의 나머지 지역

주요 시장 참여자
  • LG화학(한국)
  • Bioventus LLC(미국)
  • Seikagaku Corporation (Japan)
  • 사노피(프랑스)
  • Anika Therapeutics, Inc. (U.S.)
  • IBSA Institut Biochimique SA (Switzerland)
  • Viatris (U.S.)
  • Zimmer Biomet (U.S.)
  • Fidia Farmaceutici S.p.A. (Italy)
  • Ferring Pharmaceuticals (Switzerland
  • TRB CHEMEDICA SA (Switzerland)
  • Hangzhou Singclean Medical Products Co., Ltd. (China)
  • Hanmi Pharm. Co., Ltd. (South Korea)
  • Virchow Biotech (India)
  • Eupraxia Pharmaceuticals (Canada)

Market Opportunities

  • Advancements In Hyaluronic Acid Formulations And Delivery Systems
  • Raising Awareness and Acceptance Of Hyaluronic Acid For Knee Osteoarthritis Treatment Among Physicians And Patients

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Hyaluronic Acid Market for Knee Osteoarthritis Treatment Market Trends

“Growing Preference for Minimally Invasive and Targeted Therapies”

  • A key trend in the global Hyaluronic Acid Market for Knee Osteoarthritis Treatment is the increasing preference for minimally invasive, targeted treatment options.
  • Hyaluronic acid injections, also known as viscosupplementation, offer localized pain relief and improved joint mobility without the need for surgical intervention, making them highly attractive to both patients and clinicians
  • For instance, single and multi-injection formulations tailored to patient needs are gaining traction, offering flexibility and convenience in treatment regimens
  • The trend is further supported by advancements in injection techniques, improved formulation stability, and extended duration of therapeutic effects.
  • Additionally, the integration of imaging technologies such as ultrasound-guided injections enhances precision and patient comfort.
  • This shift towards non-surgical, effective, and patient-centric treatment options is shaping the future of knee osteoarthritis care and fueling growth in the hyaluronic acid market.

Hyaluronic Acid Market for Knee Osteoarthritis Treatment Market Dynamics

Driver

“Increasing Prevalence of Knee Osteoarthritis”

  • 전 세계 인구가 고령화됨에 따라 연골 파괴를 특징으로 하는 퇴행성 관절 질환인 골관절염의 유병률이 크게 증가할 것으로 예상됩니다. 이러한 인구 증가 추세는 골관절염이 만성 통증, 경직, 운동성 감소와 같은 증상을 유발하여 환자의 삶의 질에 심각한 영향을 미칠 수 있기 때문에 특히 우려스럽습니다. 골관절염 발병률이 증가함에 따라 많은 환자가 침습적 수술 대안을 모색함에 따라 효과적인 치료법에 대한 수요가 급증하고 있습니다. 히알루론산(HA) 주사는 환부 관절에 윤활 작용을 제공하여 관절 기능과 운동성을 향상시킴으로써 증상을 효과적으로 완화하는 최소 침습적 치료 옵션으로 각광받고 있습니다.
  • 이 주사는 활액에 자연적으로 존재하는 히알루론산을 보충하여 관절 사이의 마찰을 줄이고 충격 흡수를 향상시킵니다. 이러한 이중 작용은 통증 완화뿐만 아니라 전반적인 관절 건강도 개선하여 환자와 의료 서비스 제공자 모두에게 매력적인 선택이 될 수 있습니다.

예를 들어,

  • 2023년 12월, NCBI는 전 세계적으로 골관절염 유병률이 높으며, 고령자, 여성, 일부 인종 및 민족 집단, 그리고 사회경제적 지위가 낮은 사람들에게서 더 큰 부담이 발생한다는 연구 결과가 계속 발표되었다고 밝혔습니다. 골관절염의 가장 강력한 위험 요인은 비만과 관절 손상입니다.
  • 2024년 11월, Frontiers에서 발표한 논문에 따르면 인도의 한 연구에서는 다양한 연령대에서 KOA 유병률이 증가하는 것으로 보고되었습니다. 50세 미만은 19.2%, 50~60세는 30.7%, 60~70세는 39.7%, 70세 이상은 54.1%였습니다(23). 또 다른 연구에서는 무릎 골관절염의 유병률과 발생률이 55세 이후에 크게 증가하는 것으로 나타났습니다. 55세 이상 인구의 평균 유병률은 13.2%이며, 남성은 9.4%, 여성은 18.0%입니다.
  • 히알루론산의 효능에 대한 인식이 높아짐에 따라 의료 전문가와 환자 모두 히알루론산을 적극적으로 도입하고 있습니다. 무릎 골관절염 환자의 통증 감소와 삶의 질 향상에 히알루론산이 효능이 있다는 임상 연구 결과가 꾸준히 발표됨에 따라, 더 많은 의료 서비스 제공자들이 히알루론산을 실제 진료에 도입하고 있습니다. 이러한 히알루론산의 수용 증가와 골관절염 환자 증가는 시장 성장에 유리한 환경을 조성하여, 히알루론산 치료제의 첨단 제형 및 전달 방식을 개발하기 위한 제조업체 간의 혁신과 경쟁을 촉진합니다.

무릎 골관절염 치료 시장을 위한 히알루론산 시장

기회

“히알루론산 제형 및 전달 시스템의 발전”

  • 개선된 고분자량 및 가교 히알루론산 제품은 더 오래 지속되는 통증 완화 효과를 제공하고 주사 횟수를 줄여줍니다. 이는 효과적이고 편리한 질환 관리 솔루션을 찾는 환자에게 매력적입니다. 하이드로겔 및 나노입자 시스템과 같은 혁신적인 전달 방식은 관절 내 히알루론산의 내구성과 성능을 향상시킵니다. 이러한 발전은 고령화 사회의 증가하는 수요를 충족합니다. 기업은 이러한 기술을 활용하여 경쟁이 치열한 시장에서 두각을 나타내고 더 많은 고객을 유치할 수 있습니다. 치료 빈도를 줄이는 동시에 환자 치료 결과를 개선하는 데 중점을 둠으로써 시장의 성장 잠재력이 강화됩니다. 이러한 특징으로 인해 무릎 골관절염 치료를 위한 히알루론산 분야는 투자 및 확장에 매우 매력적인 분야입니다.

예를 들어,

  • IBSA Institut Biochimique SA, Sanofi, Seikagaku Corporation에 따르면, 각 회사는 관절 윤활, 통증 완화 및 치료 지속성을 향상시키기 위해 고유한 제형을 개발했습니다. 이러한 혁신은 향상된 유지력, 가교 기술, 그리고 환자 편의성에 중점을 두어 장기적인 증상 완화 효과를 제공합니다.
  • 2024년 4월 ScienceDirect 논문에서는 골관절염 약물 전달용 히알루론산 기반 리포좀이 커플링 화학 또는 환원적 아민화를 통한 사전 합성된 히알루론산-지질 접합체를 이용한 리포좀 제조 후 표면 기능화를 포함한다는 점을 강조했습니다. 이러한 방법은 생체적합성을 향상시키고, 다양한 약물의 동시 전달을 가능하게 하며, 접합 제어를 강화하여 효과적인 관절염 치료를 위한 리포좀 시스템을 최적화합니다.
  • 히알루론산 제형 및 전달 시스템의 발전은 무릎 골관절염 치료의 효과와 편의성을 크게 향상시킵니다. 제품 수명을 연장하고 주사 횟수를 줄임으로써 이러한 혁신은 고령화 사회에서 최소 침습 솔루션에 대한 증가하는 수요를 충족합니다. 이러한 기술을 도입하는 기업은 시장 입지를 강화하고, 더 많은 환자를 유치하며, 산업 성장을 활용할 수 있습니다. 따라서 히알루론산 기반 치료에 대한 투자는 변화하는 의료 환경에서 장기적인 성공을 위한 전략적 기회입니다.

제지/도전

"무릎 골관절염에서 히알루론산 치료의 비용 관련 과제 및 접근성 문제"

  • 무릎 골관절염 치료를 위한 히알루론산(HA) 주사는 비용이 엄청나게 많이 들 수 있으며, 특히 보험에서 전액 보장하지 않거나 혜택에서 완전히 제외되는 경우 더욱 그렇습니다. 이러한 재정적 부담으로 인해 환자는 종종 본인 부담을 하게 되는데, 이는 특히 재정적 여력이 부족한 환자에게는 상당한 부담이 될 수 있습니다.
  • 더욱이, 시간이 지남에 따라 여러 차례 주사를 맞아야 할 수 있어 치료 비용이 증가할 수 있습니다. 결과적으로, 환자들은 통증 완화 및 관절 기능 개선 효과에도 불구하고 HA 치료를 미루거나 아예 포기할 수 있습니다. 높은 치료비와 보험 적용 부족은 접근성을 제한하여 치료 격차를 야기하는 경우가 많습니다. 이러한 재정적 어려움을 해결하는 것은 더 많은 환자들이 HA 치료를 받을 수 있도록 하여 더 많은 사람들이 무릎 골관절염에 효과적인 이 치료법의 혜택을 누릴 수 있도록 하는 데 필수적입니다.

예를 들어,

  • 2024년 2월, 통증 전문의 조사 결과에 따르면, HA 주사를 맞은 환자들은, 특히 여러 차례 주사를 맞은 환자들이 코르티코스테로이드(CS) 주사를 맞거나 주사를 맞지 않은 환자들에 비해 중앙값이 상당히 높은 것으로 나타났습니다. 또한, 슬관절 전치환술(TKA)이 필요한 환자들은 HA 치료 비용이 더 높았는데, 이는 이 치료와 관련된 재정적 장벽을 여실히 보여줍니다.
  • 사노피, 에노비스, 바이오비코에 따르면, 무릎 골관절염 치료를 위한 히알루론산(HA) 치료제(신비스크 원(232.81달러) 및 바이오레복스 HA(323.53달러) 등)의 높은 가격은 접근성을 제한합니다. 많은 환자들이, 특히 보험이 없는 경우, 치료비 부담으로 어려움을 겪고 있습니다. 이러한 치료의 접근성을 개선하기 위해서는 저렴한 치료 옵션, 더 나은 보장 범위, 그리고 가격 개혁이 필수적입니다.
  • 히알루론산(HA) 주사의 높은 비용과 제한적인 보험 적용 범위는 많은 무릎 골관절염 환자에게 상당한 어려움을 야기합니다. 여러 차례 주사를 맞아야 하는 등 재정적 어려움으로 인해 통증 완화 및 관절 기능 개선 효과가 입증되었음에도 불구하고 환자들은 히알루론산(HA) 치료를 미루거나 포기하는 경우가 많습니다. 접근성을 높이고 더 많은 사람들이 이 치료의 혜택을 누릴 수 있도록 하기 위해서는 이러한 비용 관련 문제를 해결하는 것이 필수적입니다. 보험 적용 범위를 확대하고 본인 부담금을 줄이면 히알루론산 치료의 접근성이 높아져 궁극적으로 무릎 골관절염 환자들에게 더 나은 치료를 제공할 수 있을 것입니다.

무릎 골관절염 치료를 위한 히알루론산 시장 시장 범위

시장은 유형, 제품 유형, 흡수 장소, 연령대, 출처, 전달 방법, 성별 및 유통 채널을 기준으로 세분화됩니다.

분할

하위 세분화

제품 유형별
  • 제품 유형
    • (단일 주입(단상)
    • 3회 주사 요법(3상)
    • 5회 주사 요법(5상)

제형에 따라
  • 공식화
    • 가교 히알루론산
    • 비가교 히알루론산

분자량에 따라
  • 분자량
    • 고분자량(HMW) HA
    • 저분자량(LMW) HA
    • 중간 분자량 HA

치료 목표별

 
  • 치료 목표
    • 점액 보충
    • 항염 및 통증 감소
    • 연골 보호 및 재생

최종 사용자별
  • 최종 사용자
    • 병원
    • 정형외과 병원
    • 외래 수술 센터
    • 전문 통증 관리 센터

유통 채널별
  • 유통 채널
    • 직접 입찰 
    • 소매 및 온라인 약국
    • 기타

무릎 골관절염 치료 시장을 위한 히알루론산 시장

Hyaluronic Acid Market for Knee Osteoarthritis Treatment Market Regional Analysis

“North America is the Dominant Region in the Hyaluronic Acid Market for Knee Osteoarthritis Treatment”

  • North America leads the Hyaluronic Acid Market for Knee Osteoarthritis Treatment, supported by its advanced healthcare infrastructure, early adoption of non-surgical joint therapies, and the strong presence of key market players.
  • The U.S. holds a major market share due to the rising incidence of knee osteoarthritis, growing elderly population, and increasing preference for minimally invasive treatments like intra-articular hyaluronic acid injections.
  • Favorable reimbursement policies, well-established regulatory frameworks, and increased healthcare spending further contributes to the market's growth in the region.
  • Additionally, the focus on improving patient mobility and quality of life, combined with innovations in HA formulations and delivery techniques, continues to drive market expansion across North America

“Asia-Pacific is Projected to Register the Highest Growth Rate”

  • The Asia-Pacific region is projected to witness the fastest growth in the Hyaluronic Acid Market for Knee Osteoarthritis Treatment, driven by rapidly evolving healthcare infrastructure, rising awareness of joint health, and increasing demand for minimally invasive treatment options.
  • Countries such as China, India, and Japan are emerging as key markets due to the growing geriatric population and rising prevalence of knee osteoarthritis.
  • Japan, with its well-established healthcare system and high standards of elderly care, leads in the adoption of advanced HA-based viscosupplementation therapies.
  • In China and India, large patient populations, increasing healthcare investments, and growing acceptance of non-surgical osteoarthritis treatments are fueling market expansion.
  • The presence of both domestic and international HA manufacturers, along with government initiatives to improve access to orthopedic care, further accelerates market growth across the region

무릎 골관절염 치료 시장을 위한 히알루론산 시장

Hyaluronic Acid Market for Knee Osteoarthritis Treatment Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

  • LG Chem (South Korea)
  • Bioventus LLC (U.S.)
  • Seikagaku Corporation (Japan)
  • Sanofi (France)
  • Anika Therapeutics, Inc. (U.S.)
  • IBSA Institut Biochimique SA (Switzerland)
  • Viatris (U.S.)
  • Zimmer Biomet (U.S.)
  • Fidia Farmaceutici S.p.A. (Italy)
  • Ferring Pharmaceuticals (Switzerland
  • TRB CHEMEDICA SA (Switzerland)
  • Hangzhou Singclean Medical Products Co., Ltd. (China)
  • 한미약품(주)(한국)
  • Virchow Biotech(인도)
  • 유프라시아 파마슈티컬스(캐나다)

무릎 골관절염 치료를 위한 글로벌 히알루론산 시장의 최신 동향

  • 2024년 7월, LG화학은 중국 골관절염 치료 시장에 진출했습니다. 이판제약(Yifan Pharmaceutical)과 협력하여 골관절염 치료제 시노비안(Synovian) 주사제를 중국 시장에 출시했습니다. 이를 통해 LG화학은 중국 시장에 진출하고 포트폴리오를 확장할 수 있었습니다.
  • 2023년 5월, 유프락시아 파마슈티컬스(Eupraxia Pharmaceuticals)는 골관절염(OA) 치료를 목표로 하는 EP-104IAR의 2상 임상시험의 마지막 환자 방문을 완료했다고 발표했습니다. 회사는 2분기에 주요 데이터를 확보할 계획이며, 유의미한 통증 완화 및 환자 기능 개선과 더불어 유망한 안전성 프로파일을 입증할 것으로 기대하고 있습니다.
  • 2025년 3월, IBSA는 유통업체 Lunatus와 파트너십을 맺고 사우디아라비아와 UAE에서 골관절염 치료제를 확대했습니다. 이 전략적 협력은 통증 관리 솔루션을 강화하는 것을 목표로 하며, 골관절염 환자들의 선진 치료에 대한 수요 증가에 대응하기 위해 다른 지역 국가들로까지 확대될 수 있습니다.
  • 2023년 6월, 유프락시아 파마슈티컬스(Eupraxia Pharmaceuticals)는 미국 FDA가 EP-104IAR에 대해 무릎 골관절염(OA) 치료용 신속심사(Fast Track) 지정을 승인했다고 발표했습니다. 이번 지정은 개발 및 규제 검토를 신속하게 처리하여 FDA와의 협력을 더욱 원활하게 하기 위한 것입니다. 유프락시아는 2023년 2분기에 최종 데이터를 발표할 예정이며, 현재 2상 임상시험을 진행하고 있습니다. 

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 MULTIVARIATE MODELLING

2.6 TREATMENT TYPE LIFELINE CURVE

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET END USER COVERAGE GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

4.3 AVERAGE SELLING PRICE (ASP) ANALYSIS

4.4 MICRO AND MACRO ECONOMIC FACTORS

4.5 KEY PRICING STRATEGIES

4.6 HEALTHCARE ECONOMY

4.7 PENETRATION AND GROWTH PROSPECT MAPPING

4.8 TECHNOLOGY ROADMAP

4.9 VALUE CHAIN ANALYSIS

 

5 COMPANY-WISE OVERVIEW OF INTRA-ARTICULAR HYALURONIC ACID (HA) INJECTION PRODUCTS BASED ON MOLECULAR WEIGHT -

6 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, REGULATORY FRAMEWORK

6.1 NORTH AMERICA

6.2 EUROPE

6.3 ASIA-PACIFIC

6.4 MIDDLE EAST AND AFRICA

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING PREVALENCE OF KNEE OSTEOARTHRITIS

7.1.2 GROWING PREFERENCE FOR MINIMALLY INVASIVE AND NON-SURGICAL TREATMENT OPTIONS

7.1.3 CLINICAL VALIDATION OF HYALURONIC ACID IN OSTEOARTHRITIS TREATMENT

7.1.4 RECENT LAUNCHES OF HYALURONIC ACID FOR OSTEOARTHRITIS TREATMENT

7.2 RESTRAINTS

7.2.1 COMPETITION OF ALTERNATIVE THERAPIES FOR KNEE OSTEOARTHRITIS

7.2.2 REGULATORY CHALLENGES FACED BY THE MANUFACTURERS IN THE HYALURONIC ACID MARKET

7.3 OPPORTUNITIES

7.3.1 ADVANCEMENTS IN HYALURONIC ACID FORMULATIONS AND DELIVERY SYSTEMS

7.3.2 RAISING AWARENESS AND ACCEPTANCE OF HYALURONIC ACID FOR KNEE OSTEOARTHRITIS TREATMENT AMONG PHYSICIANS AND PATIENTS

7.3.3 THE IMPACT OF COMBINING HYALURONIC ACID WITH OTHER THERAPEUTIC OPTIONS FOR KNEE OSTEOARTHRITIS

7.4 CHALLENGES

7.4.1 COST-RELATED CHALLENGES AND ACCESSIBILITY CONCERNS FOR HYALURONIC ACID THERAPY IN KNEE OSTEOARTHRITIS

7.4.2 SHORT-TERM BENEFITS WITH LIMITED LASTING EFFICACY OF HYALURONIC ACID FOR KNEE OA

8 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 SINGLE INJECTION (MONOPHASIC)

8.3 THREE-INJECTION REGIMEN (TRIPHASIC)

8.4 FIVE-INJECTION REGIMEN (PENTAPHASIC)

 

9 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION

9.1 OVERVIEW

9.2 CROSS-LINKED HYALURONIC ACID

9.3 NON-CROSS-LINKED HYALURONIC ACID

10 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT

10.1 OVERVIEW

10.2 HIGH MOLECULAR WEIGHT (HMW) HA

10.3 LOW MOLECULAR WEIGHT (LMW) HA

10.4 INTERMEDIATE MOLECULAR WEIGHT HA

11 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS

11.1 OVERVIEW

11.2 VISCOSUPPLEMENTATION

11.3 ANTI-INFLAMMATORY & PAIN REDUCTION

11.4 CARTILAGE PROTECTION & REGENERATION

12 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.3 ORTHOPEDIC CLINICS

12.4 AMBULATORY SURGICAL CENTERS

12.5 SPECIALTY PAIN MANAGEMENT CENTERS

13 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER

13.3 RETAIL & ONLINE PHARMACIES

13.4 OTHERS

 

14 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION

14.1 OVERVIEW

14.2 NORTH AMERICA

14.2.1 U.S.

14.2.2 CANADA

14.2.3 MEXICO

14.3 EUROPE

14.3.1 GERMANY

14.3.2 FRANCE

14.3.3 U.K.

14.3.4 ITALY

14.3.5 SPAIN

14.3.6 RUSSIA

14.3.7 TURKEY

14.3.8 NETHERLANDS

14.3.9 SWITZERLAND

14.3.10 POLAND

14.3.11 BELGIUM

14.3.12 SWEDEN

14.3.13 AUSTRIA

14.3.14 NORWAY

14.3.15 DENMARK

14.3.16 REST OF EUROPE

14.4 ASIA-PACIFIC

14.4.1 CHINA

14.4.2 JAPAN

14.4.3 INDIA

14.4.4 SOUTH KOREA

14.4.5 AUSTRALIA

14.4.6 SINGAPORE

14.4.7 THAILAND

14.4.8 INDONESIA

14.4.9 MALAYSIA

14.4.10 TAIWAN

14.4.11 NEW ZEALAND

14.4.12 PHILIPPINES

14.4.13 VIETNAM

14.4.14 KAZAKHSTAN

14.4.15 BRUNEI

14.4.16 REST OF ASIA-PACIFIC

14.5 SOUTH AMERICA

14.5.1 BRAZIL

14.5.2 ARGENTINA

14.5.3 COLOMBIA

14.5.4 CHILE

14.5.5 PERU

14.5.6 ECUADOR

14.5.7 VENEZUELA

14.5.8 PANAMA

14.5.9 URUGUAY

14.5.10 DOMINICAN

14.5.11 REST OF SOUTH AMERICA

14.6 MIDDLE EAST AND AFRICA

14.6.1 SAUDI ARABIA

14.6.2 SOUTH AFRICA

14.6.3 UNITED ARAB EMIRATES

14.6.4 ISRAEL

14.6.5 EGYPT

14.6.6 KUWAIT

14.6.7 QATAR

14.6.8 IRAN

14.6.9 OMAN

14.6.10 ALGERIA

14.6.11 NIGERIA

14.6.12 IRAQ

14.6.13 MOROCCO

14.6.14 KENYA

14.6.15 GHANA

14.6.16 TUNISIA

14.6.17 TANZANIA

14.6.18 JORDAN

14.6.19 LIBYA

14.6.20 BAHRAIN

14.6.21 ANGOLA

14.6.22 CAMEROON

14.6.23 IVORY

14.6.24 ZIMBABWE

14.6.25 SENEGAL

14.6.26 MAURITANIA

14.6.27 TOGO

14.6.28 MAURITIUS

14.6.29 BOTSWANA

14.6.30 REST OF MIDDLE EAST AND AFRICA

15 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: GLOBAL

15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

15.3 COMPANY SHARE ANALYSIS: EUROPE

15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

16 SWOT ANALYSIS

17 COMPANY PROFILE

17.1 LG CHEM

17.1.1 COMPANY SNAPSHOT

17.1.2 REVENUE ANALYSIS

17.1.3 COMPANY SHARE ANALYSIS

17.1.4 PRODUCT PORTFOLIO

17.1.5 RECENT DEVELOPMENTS

17.2 BIOVENTUS

17.2.1 COMPANY SNAPSHOT

17.2.2 REVENUE ANALYSIS

17.2.3 COMPANY SHARE ANALYSIS

17.2.4 PRODUCT PORTFOLIO

17.2.5 RECENT DEVELOPMENT

17.3 SEIKAGAKU CORPORATION

17.3.1 COMPANY SNAPSHOT

17.3.2 REVENUE ANALYSIS

17.3.3 COMPANY SHARE ANALYSIS

17.3.4 PRODUCT PORTFOLIO

17.3.5 RECENT DEVELOPMENT

17.4 SANOFI

17.4.1 COMPANY SNAPSHOT

17.4.2 REVENUE ANALYSIS

17.4.3 COMPANY SHARE ANALYSIS

17.4.4 PRODUCT PORTFOLIO

17.4.5 RECENT DEVELOPMENT

 

17.5 ANIKA THERAPEUTICS, INC.

17.5.1 COMPANY SNAPSHOT

17.5.2 REVENUE ANALYSIS

17.5.3 COMPANY SHARE ANALYSIS

17.5.4 PRODUCT PORTFOLIO

17.5.5 RECENT DEVELOPMENT

17.6 EUPRAXIA PHARMACEUTICALS

17.6.1 COMPANY SNAPSHOT

17.6.2 REVENUE ANALYSIS

17.6.3 PRODUCT PORTFOLIO

17.6.4 RECENT DEVELOPMENT

17.7 FIDIA FARMACEUTICI S.P.A.

17.7.1 COMPANY SNAPSHOT

17.7.2 REVENUE ANALYSIS

17.7.3 PRODUCT PORTFOLIO

17.7.4 RECENT DEVELOPMENT

17.8 FERRING

17.8.1 COMPANY SNAPSHOT

17.8.2 PRODUCT PORTFOLIO

17.8.3 RECENT DEVELOPMENT

17.9 HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO.,LTD.

17.9.1 COMPANY SNAPSHOT

17.9.2 PRODUCT PORTFOLIO

17.9.3 RECENT DEVELOPMENTS

17.1 HANMI PHARM.CO., LTD

17.10.1 COMPANY SNAPSHOT

17.10.2 REVENUE ANALYSIS

17.10.3 PRODUCT PORTFOLIO

17.10.4 RECENT DEVELOPMENT

17.11 IBSA INSTITUT BIOCHIMIQUE SA.

17.11.1 COMPANY SNAPSHOT

17.11.2 PRODUCT PORTFOLIO

17.11.3 RECENT DEVELOPMENT

17.12 TRB CHEMEDICA INTERNATIONAL SA

17.12.1 COMPANY SNAPSHOT

17.12.2 PRODUCT PORTFOLIO

17.12.3 RECENT DEVELOPMENTS

 

17.13 VIATRIS INC.

17.13.1 COMPANY SNAPSHOT

17.13.2 REVENUE ANALYSIS

17.13.3 PRODUCT PORTFOLIO

17.13.4 RECENT DEVELOPMENT

17.14 VIRCHOW BIOTECH

17.14.1 COMPANY SNAPSHOT

17.14.2 PRODUCT PORTFOLIO

17.14.3 RECENT DEVELOPMENTS

17.15 ZIMMER BIOMET

17.15.1 COMPANY SNAPSHOT

17.15.2 REVENUE ANALYSIS

17.15.3 PRODUCT PORTFOLIO

17.15.4 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

표 목록

TABLE 1 COMPANY PRODUCT AND ADVANCEMENT IN FORMULATION

TABLE 2 COMPANY PRODUCT AND COMBINATION THERAPY

TABLE 3 PRICE OF THE HYALURONIC ACID INJECTION

TABLE 4 COMPANY PRODUCT AND LASTING EFFICACY

TABLE 5 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 6 GLOBAL SINGLE INJECTION (MONOPHASIC) IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 7 GLOBAL THREE-INJECTION REGIMEN (TRIPHASIC) IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 8 GLOBAL FIVE-INJECTION REGIMEN (PENTAPHASIC IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 9 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 10 GLOBAL CROSS-LINKED HYALURONIC ACID IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 11 GLOBAL NON-CROSS-LINKED HYALURONIC ACID IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 12 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 13 GLOBAL HIGH MOLECULAR WEIGHT (HMW) HA IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 14 GLOBAL LOW MOLECULAR WEIGHT (LMW) HA IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 15 GLOBAL INTERMEDIATE MOLECULAR WEIGHT HA IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 16 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 17 GLOBAL VISCOSUPPLEMENTATION IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 18 GLOBAL ANTI-INFLAMMATORY & PAIN REDUCTION IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 19 GLOBAL CARTILAGE PROTECTION & REGENERATION IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 20 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 21 GLOBAL HOSPITALS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 22 GLOBAL ORTHOPEDIC CLINICS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 23 GLOBAL AMBULATORY SURGICAL CENTERS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 24 GLOBAL SPECIALTY PAIN MANAGEMENT CENTERS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 25 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 26 GLOBAL DIRECT TENDER IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 27 GLOBAL RETAIL & ONLINE PHARMACIES IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 28 GLOBAL OTHERS IN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 29 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 30 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 31 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 32 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 33 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 34 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 35 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 36 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 37 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 38 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 39 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 40 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 41 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 42 U.S. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 43 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 44 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 45 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 46 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 47 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 48 CANADA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 49 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 50 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 51 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 52 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 53 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 54 MEXICO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 55 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 56 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 58 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 59 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 60 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 61 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 62 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 63 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 64 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 65 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 66 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 67 GERMANY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 68 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 69 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 70 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 71 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 72 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 73 FRANCE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 74 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 76 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 77 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 78 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 79 U.K. HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 80 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 81 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 82 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 83 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 84 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 85 ITALY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 86 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 87 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 88 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 89 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 90 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 91 SPAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 92 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 93 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 94 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 95 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 96 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 97 RUSSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 98 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 99 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 100 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 101 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 102 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 103 TURKEY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 104 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 105 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 106 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 107 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 108 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 109 NETHERLANDS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 110 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 112 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 113 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 114 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 115 SWITZERLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 116 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 117 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 118 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 119 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 120 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 121 POLAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 122 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 123 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 124 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 125 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 126 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 127 BELGIUM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 128 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 129 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 130 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 131 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 132 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 133 SWEDEN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 134 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 135 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 136 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 137 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 138 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 139 AUSTRIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 140 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 142 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 143 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 144 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 145 NORWAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 146 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 147 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 148 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 149 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 150 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 151 DENMARK HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 152 REST OF EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 154 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 155 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 156 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 157 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 158 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 159 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 160 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 161 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 162 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 163 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 164 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 165 CHINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 166 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 167 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 168 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 169 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 170 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 171 JAPAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 172 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 173 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 174 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 175 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 176 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 177 INDIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 178 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 179 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 180 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 181 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 182 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 183 SOUTH KOREA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 184 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 185 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 186 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 187 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 188 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 189 AUSTRALIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 190 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 191 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 192 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 193 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 194 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 195 SINGAPORE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 196 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 197 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 198 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 199 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 200 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 201 THAILAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 202 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 203 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 204 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 205 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 206 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 207 INDONESIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 208 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 209 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 210 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 211 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 212 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 213 MALAYSIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 214 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 215 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 216 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 217 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 218 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 219 TAIWAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 220 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 221 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 222 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 223 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 224 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 225 NEW ZEALAND HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 226 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 227 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 228 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 229 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 230 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 231 PHILIPPINES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 232 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 233 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 234 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 235 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 236 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 237 VIETNAM HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 238 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 239 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 240 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 241 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 242 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 243 KAZAKHSTAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 244 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 245 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 246 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 247 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 248 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 249 BRUNEI HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 250 REST OF ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 251 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 252 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 253 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 254 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 255 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 256 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 257 SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 258 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 259 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 260 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 261 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 262 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 263 BRAZIL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 264 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 265 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 266 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 267 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 268 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 269 ARGENTINA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 270 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 271 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 272 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 273 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 274 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 275 COLOMBIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 276 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 277 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 278 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 279 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 280 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 281 CHILE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 282 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 283 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 284 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 285 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 286 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 287 PERU HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 288 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 289 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 290 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 291 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 292 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 293 ECUADOR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 294 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 295 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 296 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 297 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 298 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 299 VENEZUELA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 300 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 301 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 302 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 303 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 304 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 305 PANAMA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 306 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 307 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 308 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 309 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 310 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 311 URUGUAY HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 312 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 313 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 314 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 315 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 316 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 317 DOMINICAN REPUBLIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 318 REST OF SOUTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 319 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 320 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 321 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 322 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 323 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 324 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 325 MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 326 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 327 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 328 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 329 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 330 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 331 SAUDI ARABIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 332 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 333 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 334 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 335 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 336 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 337 SOUTH AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 338 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 339 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 340 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 341 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 342 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 343 UNITED ARAB EMIRATES HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 344 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 345 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 346 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 347 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 348 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 349 ISRAEL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 350 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 351 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 352 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 353 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 354 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 355 EGYPT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 356 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 357 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 358 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 359 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 360 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 361 KUWAIT HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 362 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 363 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 364 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 365 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 366 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 367 QATAR HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 368 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 369 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 370 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 371 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 372 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 373 IRAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 374 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 375 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 376 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 377 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 378 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 379 OMAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 380 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 381 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 382 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 383 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 384 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 385 ALGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 386 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 387 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 388 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 389 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 390 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 391 NIGERIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 392 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 393 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 394 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 395 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 396 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 397 IRAQ HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 398 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 399 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 400 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 401 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 402 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 403 MOROCCO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 404 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 405 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 406 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 407 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 408 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 409 KENYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 410 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 411 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 412 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 413 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 414 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 415 GHANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 416 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 417 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 418 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 419 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 420 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 421 TUNISIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 422 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 423 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 424 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 425 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 426 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 427 TANZANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 428 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 429 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 430 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 431 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 432 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 433 JORDAN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 434 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 435 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 436 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 437 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 438 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 439 LIBYA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 440 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 441 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 442 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 443 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 444 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 445 BAHRAIN HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 446 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 447 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 448 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 449 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 450 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 451 ANGOLA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 452 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 453 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 454 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 455 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 456 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 457 CAMEROON HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 458 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 459 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 460 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 461 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 462 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 463 IVORY COAST HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 464 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 465 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 466 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 467 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 468 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 469 ZIMBABWE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 470 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 471 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 472 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 473 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 474 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 475 SENEGAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 476 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 477 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 478 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 479 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 480 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 481 MAURITANIA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 482 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 483 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 484 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 485 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 486 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 487 TOGO HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 488 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 489 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 490 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 491 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 492 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 493 MAURITIUS HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 494 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

TABLE 495 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY FORMULATION, 2018-2032 (USD THOUSAND)

TABLE 496 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY MOLECULAR WEIGHT, 2018-2032 (USD THOUSAND)

TABLE 497 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY TREATMENT GOALS, 2018-2032 (USD THOUSAND)

TABLE 498 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 499 BOTSWANA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 500 REST OF MIDDLE EAST AND AFRICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)

그림 목록

FIGURE 1 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: SEGMENTATION

FIGURE 2 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: DATA TRIANGULATION

FIGURE 3 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: DROC ANALYSIS

FIGURE 4 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: LIFELINE CURVE

FIGURE 7 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: MARKET END USER COVERAGE GRID

FIGURE 10 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: VENDOR SHARE ANALYSIS

FIGURE 11 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: SEGMENTATION

FIGURE 12 THREE SEGMENTS COMPRISE THE GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT, BY PRODUCT TYPE

FIGURE 13 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT EXECUTIVE SUMMARY

FIGURE 14 STRATEGIC DECISIONS

FIGURE 15 RISING PREVALENCE OF KNEE OSTEOARTHRITIS IS EXPECTED TO DRIVE THE GROWTH OF GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT FROM 2025 TO 2032

FIGURE 16 THE SINGLE INJECTION (MONOPHASIC) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT IN 2025 - 2032

FIGURE 17 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 18 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT IN THE FORECAST PERIOD OF 2025 TO 2032

FIGURE 19 DROC ANALYSIS

FIGURE 20 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, 2024

FIGURE 21 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 22 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, CAGR (2025-2032)

FIGURE 23 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 24 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, 2024

FIGURE 25 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, 2025-2032 (USD THOUSAND)

FIGURE 26 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, CAGR (2025-2032)

FIGURE 27 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY FORMULATION, LIFELINE CURVE

FIGURE 28 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, 2024

FIGURE 29 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, 2025-2032 (USD THOUSAND)

FIGURE 30 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, CAGR (2025-2032)

FIGURE 31 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY MOLECULAR WEIGHT, LIFELINE CURVE

FIGURE 32 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, 2024

FIGURE 33 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, 2025-2032 (USD THOUSAND)

FIGURE 34 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, CAGR (2025-2032)

FIGURE 35 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY TREATMENT GOALS, LIFELINE CURVE

FIGURE 36 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, 2024

FIGURE 37 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, 2025-2032 (USD THOUSAND)

FIGURE 38 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, CAGR (2025-2032)

FIGURE 39 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY END USER, LIFELINE CURVE

FIGURE 40 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, 2024

FIGURE 41 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, 2025-2032 (USD THOUSAND)

FIGURE 42 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 43 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: SNAPSHOT (2024)

FIGURE 45 GLOBAL HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY SHARE 2024 (%)

FIGURE 46 NORTH AMERICA HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY SHARE 2024 (%)

FIGURE 47 EUROPE HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY SHARE 2024 (%)

FIGURE 48 ASIA-PACIFIC HYALURONIC ACID MARKET FOR KNEE OSTEOARTHRITIS TREATMENT: COMPANY SHARE 2024 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

시장은 무릎 골관절염 치료를 위한 글로벌 히알루론산 시장 시장 세분화, 제품 유형별(단일 주사(단상), 3회 주사 요법(3상), 5회 주사 요법(5상)), 제형(가교 히알루론산, 비가교 히알루론산), 분자량(고분자량(HMW) HA, 저분자량(LMW) HA, 중간 분자량 HA), 치료 목표(점성 보충, 항염증 및 통증 감소, 연골 보호 및 재생), 최종 사용자(병원, 정형외과 클리닉, 외래 수술 센터, 전문 통증 관리 센터), 유통 채널(직접 입찰, 소매 및 온라인 약국, 기타), 국가(미국, 캐나다, 멕시코, 독일, 프랑스, ​​영국, 이탈리아, 러시아, 스페인, 터키, 네덜란드, 스위스, 벨기에, 스웨덴, 오스트리아, 덴마크, 노르웨이, 폴란드 및 기타 유럽 국가, 중국, 인도, 일본, 한국, 호주, 인도네시아, 태국, 말레이시아, 베트남. 필리핀, 대만, 싱가포르, 뉴질랜드, 필리핀, 카자흐스탄, 브루나이 및 기타 아시아 태평양 국가, 사우디아라비아, 남아프리카공화국, 이집트, UAE, 이스라엘, 쿠웨이트, 카타르, 이란, 오만, 알제리, 나이지리아, 이라크, 모로코, 케냐, 가나, 튀니지, 탄자니아, 요르단, 리비아, 바레인, 앙골라, 카메룬, 코트디부아르, 짐바브웨, 세네갈, 모리타니, 토고, 모리셔스, 보츠와나 및 기타 중동 및 아프리카 국가, 브라질, 아르헨티나, 칠레, 페루, 콜롬비아, 에콰도르, 베네수엘라, 파나마, 우루과이, 도미니카 공화국 및 기타 남미 국가 - 2032년까지의 산업 동향 및 전망 기준으로 세분화됩니다.
무릎 골관절염 치료를 위한 글로벌 히알루론산 시장의 시장 규모는 2024년에 2.28 USD Billion USD로 평가되었습니다.
무릎 골관절염 치료를 위한 글로벌 히알루론산 시장는 2025년부터 2032년까지 연평균 성장률(CAGR) 8.3%로 성장할 것으로 예상됩니다.
시장 내 주요 기업으로는 LG Chem, Bioventus LLC, Seikagaku Corporation가 포함됩니다.

관련 페이지 탐색

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future